124 related articles for article (PubMed ID: 33069448)
1. Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke.
Gutiérrez-Zúñiga R; Alonso de Leciñana M; Delgado-Mederos R; Gállego-Cullere J; Rodríguez-Yáñez M; Martínez-Zabaleta M; Freijo M; Portilla JC; Gil-Núñez A; Díez Sebastián J; Lisbona A; Díez-Tejedor E; Fuentes B;
Neurologia (Engl Ed); 2020 Oct; ():. PubMed ID: 33069448
[TBL] [Abstract][Full Text] [Related]
2. Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke.
Gutiérrez-Zúñiga R; Alonso de Leciñana M; Delgado-Mederos R; Gállego-Cullere J; Rodríguez-Yáñez M; Martínez-Zabaleta M; Freijo M; Portilla JC; Gil-Núñez A; Díez Sebastián J; Lisbona A; Díez-Tejedor E; Fuentes B;
Neurologia (Engl Ed); 2023 Apr; 38(3):150-158. PubMed ID: 37059570
[TBL] [Abstract][Full Text] [Related]
3. Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study.
Fuentes B; Pastor-Yborra S; Gutiérrez-Zúñiga R; González-Pérez de Villar N; de Celis E; Rodríguez-Pardo J; Gómez-de Frutos MC; Laso-García F; Gutiérrez-Fernández M; Ortega-Casarrubios M; Soto A; López-Fernández M; Santamaría M; Díez-González N; Freijo MM; Zandio B; Delgado-Mederos R; Calleja A; Portilla-Cuenca JC; Lisbona A; Otero-Ortega L; Díez-Tejedor E
J Transl Med; 2020 Nov; 18(1):414. PubMed ID: 33148277
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.
Doola R; Greer RM; Hurford R; Flatley C; Forbes JM; Todd AS; Joyce CJ; Sturgess DJ
Clin Nutr; 2019 Aug; 38(4):1707-1712. PubMed ID: 30170779
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.
Benalia M; Zeller M; Mouhat B; Guenancia C; Yameogo V; Greco C; Yao H; Maza M; Vergès B; Cottin Y
Diabetes Metab; 2019 Oct; 45(5):446-452. PubMed ID: 30763700
[TBL] [Abstract][Full Text] [Related]
6. Effect of in-hospital glycemic variability on mortality in patients with diabetes.
Jordán-Domingo M; Gimeno-Orna JA; Lahoza-Pérez MC; Ilundain-González AI; Agudo-Tabuenca A; Sáenz-Abad D
Rev Clin Esp; 2021; 221(6):323-330. PubMed ID: 32646753
[TBL] [Abstract][Full Text] [Related]
7. Effect of in-hospital glycemic variability on mortality in patients with diabetes.
Jordán-Domingo M; Gimeno-Orna JA; Lahoza-Pérez MC; Ilundain-González AI; Agudo-Tabuenca A; Sáenz-Abad D
Rev Clin Esp (Barc); 2021; 221(6):323-330. PubMed ID: 34059229
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of glycaemic variability on hospital mortality in patients hospitalised in Internal Medicine Departments.
Sáenz-Abad D; Gimeno-Orna JA; Pérez-Calvo JI
Rev Clin Esp (Barc); 2015 Dec; 215(9):479-85. PubMed ID: 26163734
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure.
Gerbaud E; Bouchard de La Poterie A; Baudinet T; Montaudon M; Beauvieux MC; Lemaître AI; Cetran L; Seguy B; Picard F; Vélayoudom FL; Ouattara A; Kabore R; Coste P; Domingues-Dos-Santos P; Catargi B
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329874
[TBL] [Abstract][Full Text] [Related]
10. Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia.
Kim SH; Kim JY; Kim ES; Park IR; Ha EY; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Ann Med; 2022 Dec; 54(1):2736-2743. PubMed ID: 36205625
[TBL] [Abstract][Full Text] [Related]
11. Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition.
Farrokhi F; Chandra P; Smiley D; Pasquel FJ; Peng L; Newton CA; Umpierrez GE
Endocr Pract; 2014 Jan; 20(1):41-5. PubMed ID: 24013986
[TBL] [Abstract][Full Text] [Related]
12. Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.
Umpierrez GE; O'Neal D; DiGenio A; Goldenberg R; Hernandez-Triana E; Lin J; Park CY; Renard E; Kovatchev B
Diabetes Obes Metab; 2017 Sep; 19(9):1317-1321. PubMed ID: 28256054
[TBL] [Abstract][Full Text] [Related]
13. High glycemic variability: An underestimated determinant of stroke functional outcome following large vessel occlusion.
Baudu J; Gerbaud E; Catargi B; Montaudon M; Beauvieux MC; Sagnier S; Debruxelles S; Renou P; Poli M; Olindo S; Couture M; Marnat G; Sibon I
Rev Neurol (Paris); 2022 Sep; 178(7):732-740. PubMed ID: 35219541
[TBL] [Abstract][Full Text] [Related]
14. The application of simple metrics in the assessment of glycaemic variability.
Monnier L; Colette C; Owens DR
Diabetes Metab; 2018 Sep; 44(4):313-319. PubMed ID: 29602622
[TBL] [Abstract][Full Text] [Related]
15. Critical illness myopathy precedes hyperglycaemia and high glucose variability.
Mörgeli R; Wollersheim T; Engelhardt LJ; Grunow JJ; Lachmann G; Carbon NM; Koch S; Spies C; Weber-Carstens S
J Crit Care; 2021 Jun; 63():32-39. PubMed ID: 33592497
[TBL] [Abstract][Full Text] [Related]
16. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Johnston KC; Bruno A; Pauls Q; Hall CE; Barrett KM; Barsan W; Fansler A; Van de Bruinhorst K; Janis S; Durkalski-Mauldin VL;
JAMA; 2019 Jul; 322(4):326-335. PubMed ID: 31334795
[TBL] [Abstract][Full Text] [Related]
17. Glycemic variability and mortality in critically ill patients: the impact of diabetes.
Krinsley JS
J Diabetes Sci Technol; 2009 Nov; 3(6):1292-301. PubMed ID: 20144383
[TBL] [Abstract][Full Text] [Related]
18. Insulin for glycaemic control in acute ischaemic stroke.
Bellolio MF; Gilmore RM; Ganti L
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005346. PubMed ID: 24453023
[TBL] [Abstract][Full Text] [Related]
19. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Rydén L; Wedel H; Vestberg D; Lind M
Eur Heart J; 2013 Feb; 34(5):374-9. PubMed ID: 23144046
[TBL] [Abstract][Full Text] [Related]
20. Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke.
Du LZ; Liu PY; Ge CY; Li Y; Li YY; Tang MF; Chen JJ
Neuropsychiatr Dis Treat; 2022; 18():1309-1314. PubMed ID: 35799799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
